The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: a systematic review and meta …
X Zhou, J Liu, J Pan, Z Xu, J Xu - BMC pulmonary medicine, 2022 - Springer
Background The respiratory rate-oxygenation (ROX) index has been increasingly applied to
predict the outcome of high-flow nasal cannula (HFNC) in pneumonia patients with acute …
predict the outcome of high-flow nasal cannula (HFNC) in pneumonia patients with acute …
Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis
CE Yau, DYX Lee, A Vasudevan, KJ Goh, E Wong… - Critical Care, 2023 - Springer
COVID-19 patients with acute hypoxemic respiratory failure (AHRF) benefit from high flow
nasal cannula (HFNC) oxygen therapy. However, delays in initiating invasive ventilation …
nasal cannula (HFNC) oxygen therapy. However, delays in initiating invasive ventilation …
ROX 指数预测老年重症社区获得性肺炎患者气管插管的有效性分析
王重阳， 王璐， 郭仁楠， 沙丽恒， 肖东 - 临床急诊杂志, 2022 - lcjz.whuhzzs.com
目的探讨ROX 指数预测老年重症社区获得性肺炎(SCAP) 患者气管插管的有效性.
方法选取既往于2022 年1 月1 日—2022 年9 月1 日新疆维吾尔自治区人民医院EICU 收治的71 …
方法选取既往于2022 年1 月1 日—2022 年9 月1 日新疆维吾尔自治区人民医院EICU 收治的71 …
Characteristics of unvaccinated and vaccinated critically ill COVID-19 patients in calabria region (Italy): a retrospective study
A Bruni, F Longhini, S Macheda, E Biamonte… - Frontiers in …, 2022 - frontiersin.org
Introduction After the rapid surge of a novel coronavirus (SARS-CoV-2) in 2020 anti-SARS-
CoV-2 vaccines have been developed to prevent the development of critical forms of COVID …
CoV-2 vaccines have been developed to prevent the development of critical forms of COVID …
Derivation and validation of a predictive score for respiratory failure worsening leading to secondary intubation in COVID-19: the ceres score
A Gaudet, B Ghozlan, A Dupont… - Journal of Clinical …, 2022 - mdpi.com
Predictive scores assessing the risk of respiratory failure in COVID-19 mostly focused on the
prediction of early intubation. A combined assessment of clinical parameters and biomarkers …
prediction of early intubation. A combined assessment of clinical parameters and biomarkers …
Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study
R Hirabayashi, K Nagata, Y Sato, A Nakagawa… - BMC Pulmonary …, 2023 - Springer
Background High-flow nasal cannula (HFNC) therapy is an important non-invasive
respiratory support in acute respiratory failure, including coronavirus disease (COVID-19) …
respiratory support in acute respiratory failure, including coronavirus disease (COVID-19) …
The COVID-19 driving force: How it shaped the evidence of non-invasive respiratory support
Y Jalil, M Ferioli, M Dres - Journal of Clinical Medicine, 2023 - mdpi.com
During the COVID-19 pandemic, the use of non-invasive respiratory support (NIRS) became
crucial in treating patients with acute hypoxemic respiratory failure. Despite the fear of viral …
crucial in treating patients with acute hypoxemic respiratory failure. Despite the fear of viral …
[HTML][HTML] Effectiveness of high-flow nasal cannula therapy on clinical outcomes in adults with COVID-19: A systematic review
DG Arruda, GA Kieling, LL Melo-Diaz - Canadian Journal of …, 2023 - ncbi.nlm.nih.gov
Methods A systematic literature search was conducted in the PubMed, EMBASE and
SCOPUS databases, and the study was prepared according to the Preferred Reporting …
SCOPUS databases, and the study was prepared according to the Preferred Reporting …
[HTML][HTML] Ratio of Oxygen Saturation to Inspired Oxygen, ROX Index, Modified ROX Index to Predict High Flow Cannula Success in COVID-19 Patients: Multicenter …
O Ruangsomboon, S Jirathanavichai… - Western Journal of …, 2023 - ncbi.nlm.nih.gov
Methods We conducted this multicenter retrospective study at five EDs in Thailand between
January–December 2021. Adult patients with COVID-19 treated with HFNC in the ED were …
January–December 2021. Adult patients with COVID-19 treated with HFNC in the ED were …
Choice of respiratory therapy for COVID-19 patients with acute hypoxemic respiratory failure: a retrospective case series study
K Sudo, T Sawa, K Kushimoto, R Yoshii, K Yuasa… - PeerJ, 2023 - peerj.com
Background In the treatment of acute hypoxemic respiratory failure (AHRF) due to
coronavirus 2019 (COVID-19), physicians choose respiratory management ranging from low …
coronavirus 2019 (COVID-19), physicians choose respiratory management ranging from low …